Abstract

We demonstrated the metabolic benefits of Parabacteroides distasonis (PD) on decreasing weight gain, hyperglycemia, and hepatic steatosis in ob/ob and high-fat diet (HFD)-fed mice. Treatment with live P. distasonis (LPD) dramatically altered the bile acid profile with elevated lithocholic acid (LCA) and ursodeoxycholic acid (UDCA) and increased the level of succinate in the gut. In vitro cultivation of PD demonstrated its capacity to transform bile acids and production of succinate. Succinate supplementation in the diet decreased hyperglycemia in ob/ob mice via the activation of intestinal gluconeogenesis (IGN). Gavage with a mixture of LCA and UDCA reduced hyperlipidemia by activating the FXR pathway and repairing gut barrier integrity. Co-treatment with succinate and LCA/UDCA mirrored the benefits of LPD. The binding target of succinate was identified as fructose-1,6-bisphosphatase, the rate-limiting enzyme in IGN. The succinate and secondary bile acids produced by P. distasonis played key roles in the modulation of host metabolism.

Keywords

ObesityChemistryBiochemistryMedicineEndocrinology

Affiliated Institutions

Related Publications

Publication Info

Year
2019
Type
article
Volume
26
Issue
1
Pages
222-235.e5
Citations
1123
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1123
OpenAlex

Cite This

Kai Wang, Mingfang Liao, Nan Zhou et al. (2019). Parabacteroides distasonis Alleviates Obesity and Metabolic Dysfunctions via Production of Succinate and Secondary Bile Acids. Cell Reports , 26 (1) , 222-235.e5. https://doi.org/10.1016/j.celrep.2018.12.028

Identifiers

DOI
10.1016/j.celrep.2018.12.028